BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 31711182)

  • 1. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
    Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
    Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
    Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma.
    Jiang Y; Qu S; Pan X; Huang S; Zhu X
    Sci Rep; 2020 Jan; 10(1):861. PubMed ID: 31965045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
    Wu S; Xia B; Han F; Xie R; Song T; Lu L; Yu W; Deng X; He Q; Zhao C; Xie C
    PLoS One; 2015; 10(8):e0134491. PubMed ID: 26248338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.
    Liang W; Shen G; Zhang Y; Chen G; Wu X; Li Y; Li A; Kang S; Yuan X; Hou X; Huang P; Huang Y; Zhao H; Tian Y; Zhao C; Zhang L
    Chin J Cancer; 2016 Nov; 35(1):98. PubMed ID: 27887636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal of a Pretreatment Nomogram for Predicting Local Recurrence after Intensity-Modulated Radiation Therapy in T4 Nasopharyngeal Carcinoma: A Retrospective Review of 415 Chinese Patients.
    Zhang LL; Li YY; Hu J; Zhou GQ; Chen L; Li WF; Lin AH; Ma J; Qi ZY; Sun Y
    Cancer Res Treat; 2018 Oct; 50(4):1084-1095. PubMed ID: 29141396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
    Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
    Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.
    Tang LQ; Li CF; Li J; Chen WH; Chen QY; Yuan LX; Lai XP; He Y; Xu YX; Hu DP; Wen SH; Peng YT; Zhang L; Guo SS; Liu LT; Guo L; Wu YS; Luo DH; Huang PY; Mo HY; Xiang YQ; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Cao KJ; Qian CN; Guo X; Zeng YX; Mai HQ; Zeng MS
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26467665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up.
    Sun XS; Li XY; Xiao BB; Liu SL; Chen QY; Tang LQ; Mai HQ
    Oral Oncol; 2020 Jan; 100():104490. PubMed ID: 31790913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.
    OuYang PY; You KY; Zhang LN; Xiao Y; Zhang XM; Xie FY
    Cancer Commun (Lond); 2018 Sep; 38(1):55. PubMed ID: 30176932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy.
    Zeng L; Guo P; Li JG; Han F; Li Q; Lu Y; Deng XW; Zhang QY; Lu TX
    Oncotarget; 2015 Nov; 6(36):39373-83. PubMed ID: 26415223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
    Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis.
    Huang XD; Zhou GQ; Lv JW; Zhou HQ; Zhong CW; Wu CF; Zheng ZQ; He XJ; Peng L; Ma J; Sun Y
    Radiother Oncol; 2018 Nov; 129(2):389-395. PubMed ID: 30270098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Pan XB; Liu Y; Li L; Qu S; Chen L; Liang SX; Chen KH; Liang ZG; Zhu XD
    Aging (Albany NY); 2020 Jan; 12(2):1857-1866. PubMed ID: 32005029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
    Li WZ; Liu GY; Lin LF; Lv SH; Qiang MY; Lv X; Wu YS; Liang H; Ke LR; Wang DL; Yu YH; Qiu WZ; Liu KY; Guo X; Li JP; Zou YJ; Xiang YQ; Xia WX
    Radiother Oncol; 2020 Apr; 145():101-108. PubMed ID: 31931288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of radiologic extranodal extension in locoregionally advanced nasopharyngeal carcinoma with lymph node metastasis: a comprehensive nomogram.
    Ding J; Chen J; Lin Y; Hong J; Huang C; Fei Z; Chen C
    Braz J Otorhinolaryngol; 2024; 90(2):101363. PubMed ID: 38101121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms for predicting long-term survival in patients with non-metastatic nasopharyngeal carcinoma in an endemic area.
    Zeng Q; Hong MH; Shen LJ; Meng XQ; Guo X; Qian CN; Wu PH; Huang PY
    Oncotarget; 2016 May; 7(20):29708-19. PubMed ID: 27102440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
    Yao JJ; Zhang F; Gao TS; Zhang WJ; Lawrence WR; Zhu BT; Zhou GQ; Ma J; Wang SY; Sun Y
    Radiother Oncol; 2019 Mar; 132():178-187. PubMed ID: 30448002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram for the prediction of cerebrovascular disease among patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
    Cai J; Cheng J; Li H; Lin WJ; Li Y; Zhuo X; Huang X; Simone CB; Aronow WS; Chow ELW; Tang Y
    Radiother Oncol; 2019 Mar; 132():34-41. PubMed ID: 30825967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.